130 Interpretation

130 Ìý±õ²Ô³Ù±ð°ù±è°ù±ð³Ù²¹³Ù¾±´Ç²Ô

(1)     In this Act, except so far as the context otherwise requires—

[“Agreement on a Unified Patent Court†means the Agreement on a Unified Patent Court signed at Brussels on 19th February 2013;]

[“application fee†means the fee prescribed for the purposes of section 14(1A) above;]

“application for a European patent (UK)†and [(subject to subsection (4A) below)] “international application for a patent (UK)†each mean an application of the relevant description which, on its date of filing, designates the United Kingdom;

“appointed dayâ€, in any provision of this Act, means the day appointed under section 132 below for the coming into operation of that provision;

[“biological material†means any material containing genetic information and capable of reproducing itself or being reproduced in a biological system;

“biotechnological invention†means an invention which concerns a product consisting of or containing biological material or a process by means of which biological material is produced, processed or used;]

“Community Patent Convention†means the Convention for the European Patent for the Common Market . . .;

“comptroller†means the Comptroller-General of Patents, Designs and Trade Marks;

“Convention on International Exhibitions†means the Convention relating to International Exhibitions signed in

Powered by Lexis+®

Popular documents